Immune cell ratio predicts health trajectories in global aging study

Researchers analyzed immune cells from cohorts spanning multiple countries to map how our immune system changes with age and what predicts healthier aging trajectories. The standout finding: the ratio of GZMK-expressing to GZMB-expressing effector memory T cells appears to be a biomarker for health outcomes. GZMK+ and GZMB+ cells are both cytotoxic T cells that fight infections, but they differ in their inflammatory profiles and tissue-homing behaviors. A higher proportion of GZMK+ cells relative to GZMB+ cells was associated with better health trajectories. This matters because it offers a potentially measurable immune signature that could help identify who's aging well versus who might benefit from interventions. The global scope strengthens confidence that this isn't population-specific. While we need prospective validation and mechanistic studies to understand whether this ratio is causal or just correlative, having a single-cell-resolution immune aging marker could eventually guide personalized immunology-based interventions for healthspan extension.